EP3801641 - COMPOSITIONS AND METHODS FOR THE MODULATION OF ADAPTIVE IMMUNITY [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.03.2021 Database last updated on 31.05.2024 | |
Former | The international publication has been made Status updated on 14.12.2019 | Most recent event Tooltip | 13.04.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Locanabio, Inc. 3545 John Hopkins Court Suite 200 San Diego CA 92121 / US | [2021/15] | Inventor(s) | 01 /
NELLES, David A. 7770 Regents Road San Diego, California 92122 / US | 02 /
BATRA, Ranjan 7770 Regents Road San Diego, California 92122 / US | 03 /
YEO, Eugene 7770 Regents Road San Diego, California 92122 / US | [2021/15] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [N/P] |
Former [2021/15] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | Application number, filing date | 19814000.6 | 07.06.2019 | [2021/15] | WO2019US36050 | Priority number, date | US201862682276P | 08.06.2018 Original published format: US 201862682276 P | [2021/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019236998 | Date: | 12.12.2019 | Language: | EN | [2019/50] | Type: | A1 Application with search report | No.: | EP3801641 | Date: | 14.04.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.12.2019 takes the place of the publication of the European patent application. | [2021/15] | Search report(s) | International search report - published on: | US | 12.12.2019 | (Supplementary) European search report - dispatched on: | EP | 26.08.2022 | Classification | IPC: | A61K48/00, C12N9/22, C12N15/62 | [2021/15] | CPC: |
C12N15/90 (EP,KR);
C12N15/113 (KR);
C12N15/11 (US);
A61K48/005 (US);
C12N15/102 (KR);
C12N15/1136 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/15] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION VON ADAPTIVER IMMUNITÄT | [2021/15] | English: | COMPOSITIONS AND METHODS FOR THE MODULATION OF ADAPTIVE IMMUNITY | [2021/15] | French: | COMPOSITIONS ET PROCÉDÉS DE MODULATION DE L'IMMUNITÉ ADAPTATIVE | [2021/15] | Entry into regional phase | 06.01.2021 | National basic fee paid | 06.01.2021 | Search fee paid | 06.01.2021 | Designation fee(s) paid | 06.01.2021 | Examination fee paid | Examination procedure | 06.01.2021 | Examination requested [2021/15] | 21.03.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 14.06.2021 | Renewal fee patent year 03 | 31.03.2022 | Renewal fee patent year 04 | 31.03.2023 | Renewal fee patent year 05 | 12.04.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY] - OMAR O ABUDAYYEH ET AL, "RNA targeting with CRISPR-Cas13", NATURE, London, (20171004), vol. 550, no. 7675, doi:10.1038/nature24049, ISSN 0028-0836, pages 280 - 284, XP055529736 [I] 9-15 * figure 1g * [Y] 1-8 DOI: http://dx.doi.org/10.1038/nature24049 | [XY] - JIANGTAO REN ET AL, "Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition", CLINICAL CANCER RESEARCH, US, (20161104), vol. 23, no. 9, doi:10.1158/1078-0432.CCR-16-1300, ISSN 1078-0432, pages 2255 - 2266, XP055565027 [X] 1-7 * abstract * [Y] 1-8 DOI: http://dx.doi.org/10.1158/1078-0432.CCR-16-1300 | [Y] - DAVID A. NELLES ET AL, "Applications of Cas9 as an RNA-programmed RNA-binding protein", BIOESSAYS, GB, (20150416), vol. 37, no. 7, doi:10.1002/bies.201500001, ISSN 0265-9247, pages 732 - 739, XP055345194 [Y] 1-8 * page 736; figure 1 * DOI: http://dx.doi.org/10.1002/bies.201500001 | [Y] - SHI C ET AL, "beta2-Microglobulin: emerging as a promising cancer therapeutic target", DRUG DISCOVERY TODAY, ELSEVIER, AMSTERDAM, NL, vol. 14, no. 1-2, doi:10.1016/J.DRUDIS.2008.11.001, ISSN 1359-6446, (20090101), pages 25 - 30, (20090101), XP025868046 [Y] 1-8 * page 28 * DOI: http://dx.doi.org/10.1016/j.drudis.2008.11.001 | [Y] - WIEGMANN BETTINA ET AL, "Prevention of rejection of allogeneic endothelial cells in a biohybrid lung by silencing HLA-class I expression", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, (20140621), vol. 35, no. 28, doi:10.1016/J.BIOMATERIALS.2014.06.007, ISSN 0142-9612, pages 8123 - 8133, XP028861826 [Y] 1-8 * page 8124 * DOI: http://dx.doi.org/10.1016/j.biomaterials.2014.06.007 | [Y] - LIANG CAIXIA ET AL, "RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats", JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (20160503), vol. 297, doi:10.1016/J.JNEUROIM.2016.05.002, ISSN 0165-5728, pages 28 - 37, XP029631257 [Y] 1-8 * page 29 * DOI: http://dx.doi.org/10.1016/j.jneuroim.2016.05.002 | [Y] - SILVANA KONERMANN ET AL, "Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors", CELL, Amsterdam NL, (20180419), vol. 173, no. 3, doi:10.1016/j.cell.2018.02.033, ISSN 0092-8674, pages 665 - 676, XP055529705 [Y] 1-8 * abstract * DOI: http://dx.doi.org/10.1016/j.cell.2018.02.033 | International search | [Y]WO2017091630 (UNIV CALIFORNIA [US], et al) [Y] 14, 25 * entire document *; | [XY]WO2017093969 (NOVARTIS AG [CH], et al) [X] 1-13, 15 * entire document * [Y] 14, 16-30; | [A]WO2018081806 (UNIV FLORIDA [US]) [A] 1-30* entire document *; | [XP]WO2018170333 (BROAD INST INC [US], et al) [XP] 1-30 * entire document *; | [Y] - COX et al., "RNA editing with CRISPR-Cas13", Science, (20171124), vol. 358, no. 6366, pages 1019 - 1027, XP055491658 [Y] 16-30 * . entire document * DOI: http://dx.doi.org/10.1126/science.aaq0180 |